6. De Amorim Bernstein K, DeLaney T: Chordomas and chondrosarcomas – the role of radiation therapy. J Surg Oncol 2016; 114: 564–69

7. Dietlein M, Feaux de Lacroix W, Neufang KF, Steinbrich W, Schmidt J: [Assessment of the grading of cartilaginous tumors of the long tubular bones from the radiologic and pathologic viewpoint]. Rontgenblatter 1990; 43: 174–80

8. Dürr HR, Bakhshai Y, Rechl H, Tunn PU: [Resection margins in bone tumors: what is adequate?]. Unfallchirurg 2014; 117: 593–9

9. Dürr HR, Tunn PU, Bakhshai Y: [Surveillance in patients with bone sarcomas. When, how, and for how long?]. Unfallchirurg 2014; 117: 523–7

10. Enneking WF: A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 1986; 204: 9–24

11. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106–20

12. Geirnaerdt MJ, Hogendoorn PC, Bloem JL, Taminiau AH, van der Woude HJ: Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 2000; 214: 539–46

13. Grimer RJ, Aydin BK, Wafa H, Carter SR, Jeys L, Abudu A, Parry M: Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone. Bone Joint J 2016; 98-B: 857–64

14. Hickey M, Farrokhyar F, Deheshi B, Turcotte R, Ghert M: A systematic review and meta-analysis of intralesional versus wide resection for intramedullary grade I chondrosarcoma of the extremities. Ann Surg Oncol 2011; 18: 1705–9

15. http://www.krebsdaten.de

16. Jürgens H, Exner U, Gadner H et al.: Multidisciplinary treatment of primary Ewing‘s sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 1988; 61: 23–32

17. Kawaguchi S, Sun T, Lin PP, Deavers M, Harun N, Lewis VO: Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma? Clin Orthop Relat Res 2014; 472: 983–9

18. Leerapun T, Hugate RR, Inwards CY, Scully SP, Sim FH: Surgical management of conventional grade I chondrosarcoma of long bones. Clin Orthop Relat Res 2007; 463: 166–72

19. Lindner L et al.: Manual Knochentumoren und Weichteilsarkome, 6. Auflage. Germering: Zuckschwerdt, 2017

20. Liu J, Hudkins PG, Swee RG, Unni KK: Bone sarcomas associated with Ollier‘s disease. Cancer 1987; 59: 1376–85

21. McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG: The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 2004; 85: 68–76

22. Picci P, Manfrini M, Fabbri N, Gambarotti M, Vanel D: Atlas of musculo-skeletal tumors and tumorlike lesions. Springer, 2014

23. Pratt CB, Meyer WH, Rao BN et al.: Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site. Cancer 1997; 80: 1171–7

24. Sadoski C, Suit HD, Rosenberg A, Mankin H, Efird J: Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol 1993; 52: 223–30

25. Sajadi KR, Heck RK, Neel MD et al.: The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop Relat Res 2004; 426: 92–6

26. Schuck A, Ahrens S, Paulussen M et al.: Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55: 168–77

27. Schwartz HS, Zimmerman NB, Simon MA, Wroble RR, Millar EA, Bonfiglio M: The malignant potential of enchondromatosis. J Bone Joint Surg Am 1987; 69: 269–74

28. Whelan J et al: Efficacy of busulfan-melphalan hemotherapy consolidation (BuMel) in localized high-risk Ewing sarcoma (ES): Results of EURO-Ewing-99-R2 randomized trial (EE99R-2Loc). J Clin Oncol 2016: 34 (Suppl): abstr 11000